Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential - PubMed (original) (raw)

Comparative Study

Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential

W M Franz et al. EMBO J. 1989 Jan.

Abstract

The requirements for the oncogenic conversion of the c-abl proto-oncogene have been determined by the expression of N-terminal deleted forms and viral gag-fused forms of the c-abl proteins from a selectable retroviral vector. To activate the transforming potential of c-abl, it is necessary that (i) specific N-terminal amino acids are deleted to release the kinase from negative regulation in vivo; (ii) an N-terminal myristylation site is part of the activated kinase; (iii) the fatty-acylated, activated kinase is overproduced. The N-terminal amino acids found to be necessary for the cellular inhibition of c-abl tyrosine phosphorylation are part of a homologous region present in many non-receptor tyrosine kinases, the v-crk oncogene and phospholipase C-II. Overproduction of a deregulated and myristylated c-abl tyrosine kinase induces the transformation of NIH 3T3 cells.

PubMed Disclaimer

References

1. Virology. 1973 Apr;52(2):456-67 - PubMed
1. Cell. 1980 Dec;22(3):777-85 - PubMed
1. J Virol. 1982 Jan;41(1):271-85 - PubMed
1. Nature. 1982 Dec 23;300(5894):765-7 - PubMed
1. J Virol. 1983 Mar;45(3):1195-9 - PubMed

Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential - PubMed (original) (raw)